Hikma Pharmaceuticals PLC
LSE:HIK

Watchlist Manager
Hikma Pharmaceuticals PLC Logo
Hikma Pharmaceuticals PLC
LSE:HIK
Watchlist
Price: 1 950 GBX 4.17% Market Closed
Market Cap: 4.3B GBX
Have any thoughts about
Hikma Pharmaceuticals PLC?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

111.7
Current
102.3
Median
13.3
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
111.7
=
Enterprise Value
74.5B GBX
/
EBITDA
836m USD
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
1.1
2-Years Forward
EV/EBITDA
1.1
3-Years Forward
EV/EBITDA
1

See Also

Discover More